| D-mannose suppresses macrophage IL-1β production S Torretta, A Scagliola, L Ricci, F Mainini, S Di Marco, I Cuccovillo, ... Nature communications 11 (1), 6343, 2020 | 146 | 2020 |
| Lipid and polymer-based nanoparticle siRNA delivery systems for cancer therapy F Mainini, MR Eccles Molecules 25 (11), 2692, 2020 | 142 | 2020 |
| Improved paramagnetic liposomes for MRI visualization of pH triggered release E Torres, F Mainini, R Napolitano, F Fedeli, R Cavalli, S Aime, E Terreno Journal of controlled release 154 (2), 196-202, 2011 | 71 | 2011 |
| In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes DD Castelli, W Dastrù, E Terreno, E Cittadino, F Mainini, E Torres, ... Journal of Controlled Release 144 (3), 271-279, 2010 | 71 | 2010 |
| Intratumoral combination therapy with poly (I: C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity C Anfray, F Mainini, E Digifico, A Maeda, M Sironi, M Erreni, A Anselmo, ... Journal for immunotherapy of cancer 9 (9), 2021 | 57 | 2021 |
| The tricarboxylic acid cycle at the crossroad between cancer and immunity A Scagliola, F Mainini, S Cardaci Antioxidants & redox signaling 32 (12), 834-852, 2020 | 47 | 2020 |
| HER-2-targeted nanoparticles for breast cancer diagnosis and treatment L Sitia, M Sevieri, L Signati, A Bonizzi, A Chesi, F Mainini, F Corsi, ... Cancers 14 (10), 2424, 2022 | 29 | 2022 |
| Arginine-based Poly (I: C)-loaded nanocomplexes for the polarization of macrophages toward M1-antitumoral effectors TG Dacoba, C Anfray, F Mainini, P Allavena, MJ Alonso, F Torres Andón, ... Frontiers in Immunology 11, 1412, 2020 | 29 | 2020 |
| Protein-based nanoparticles for the imaging and treatment of solid tumors: the case of ferritin nanocages, a narrative review F Mainini, A Bonizzi, M Sevieri, L Sitia, M Truffi, F Corsi, S Mazzucchelli Pharmaceutics 13 (12), 2000, 2021 | 22 | 2021 |
| Nanoparticles for immunotherapy C Anfray, F Mainini, FT Andón Frontiers of nanoscience 16, 265-306, 2020 | 14 | 2020 |
| Nanobiotechnology and immunotherapy: Two powerful and cooperative allies against cancer F Mainini, F De Santis, G Fucà, M Di Nicola, L Rivoltini, M Eccles Cancers 13 (15), 3765, 2021 | 7 | 2021 |
| Polymeric vesicles loaded with gadoteridol as reversible and concentration-independent magnetic resonance imaging thermometers A Sanino, W Dastru, F Mainini, DD Castelli, S Aime, E Terreno Journal of biomedical nanotechnology 10 (8), 1620-1626, 2014 | 7 | 2014 |
| Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis L Ricci, FU Stanley, T Eberhart, F Mainini, D Sumpton, S Cardaci Cell Death & Disease 14 (7), 403, 2023 | 6 | 2023 |
| Bridging small molecules to modified bacterial microparticles using a disulphide linkage: MIS416 as a cargo delivery system F Mainini, DS Larsen, GA Webster, SL Young, MR Eccles Plos one 10 (12), e0145403, 2015 | 4 | 2015 |
| D-mannose suppresses macrophage IL-1β production. Nat Commun. 2020 Dec 11; 11 (1): 6343 S Torretta, A Scagliola, L Ricci, F Mainini, S Di Marco, I Cuccovillo, ... | 4 | |
| MIS416 as a siRNA Delivery System with the Ability to Target Antigen-Presenting Cells F Mainini, DS Larsen, GA Webster, SL Young, MR Eccles nucleic acid therapeutics 28 (4), 225-232, 2018 | 2 | 2018 |
| Nanotherapeutics approaches to improve the efficacy of CAR-T cells in solid tumors F Mainini Biocell 45 (5), 1171, 2021 | 1 | 2021 |
| Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant … M Sevieri, F Andreata, F Mainini, L Signati, F Piccotti, M Truffi, A Bonizzi, ... Journal of Nanobiotechnology 22 (1), 184, 2024 | | 2024 |
| Publisher Correction: Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients … M Sevieri, F Andreata, F Mainini, L Signati, F Piccotti, M Truffi, A Bonizzi, ... Journal of Nanobiotechnology 22, 2024 | | 2024 |
| Abstract P4-07-18: FerOX, an anthracyclines nanoformulation to lead toward immuno-mediated cancer remission, preserving T-cell immune competence S Mazzucchelli, F Mainini, F Andreata, M Truffi, A Bonizzi, F Piccotti, ... Cancer Research 83 (5_Supplement), P4-07-18-P4-07-18, 2023 | | 2023 |
